/ /

CLINICAL

Future of DME resting on new mechanisms of actionWhen it comes to finding new treatments for diabetic macular edema (DME), there is no shortage of promising targets, said Peter A. Campochiaro, MD. He presented an overview of future compounds with various mechanisms of action that may change how clinicians treat DME.
Introducing 3-D OCT to live surgery
Introducing 3-D OCT to live surgeryThe advent of three-dimensional optical coherence tomography to live surgery may bring greater clarity to how ophthalmologists visualize structures and how they operate.
Drug therapies, delivery systems advance for glaucoma carePharmacologic products and devices in development continue to gain momentum in the glaucoma treatment armamentarium.
MIGS devices lead glaucoma surgical innovation in 2016A single event stood out in everyone’s mind when Ophthalmology Times asked experts to think back on the year in glaucoma surgery: the July 29 approval by the U.S. Food and Drug Administration (FDA) of the CyPass Micro-Stent.
Researchers reject vitamin D role in macular degeneration
Researchers reject vitamin D role in macular degenerationAnalyzing data from the European Eye Study, Gareth J. McKay, PhD, of Queen’s University in Belfast, United Kingdom, and colleagues in 7 countries in Europe found no meaningful association between serum 25-hydroxy vitamin D (25(OH)D) and AMD. They published the finding in Ophthalmology.
Choosing the right treatment for proliferative diabetic retinopathy
Choosing the right treatment for proliferative diabetic retinopathyRetina specialists who are Diabetic Retinopathy Clinical Research Network investigators offer views on whether laser panretinal photocoagulation or anti-VEGF therapy deserves consideration as first-line treatment for proliferative diabetic retinopathy.
Visual phenomena, decreased vision secondary to occipital lobe infarct
Visual phenomena, decreased vision secondary to occipital lobe infarctMicroperimetry aids diagnosis, and supplements increase circulation
6 OCT pitfalls to avoidOptometry has widely adopted optical coherence tomography (OCT) as a mainstay in diagnosing and managing ocular disease since its advent in the 1990s
Details matter when prescribing meso-zeaxanthinRecently, there has been interest by pediatric ophthalmology in protecting our most valuable retinal real estate, the fovea, with dietary zeaxanthin
How to establish value in the minds of contact lens wearersDifferentiate yourself in this era of heightened competition